Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05832996 · ClinicalTrials.gov registry record · Phase 4
Cool vs Room-temperature Artificial Tears
A Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT05832996 is a Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease that has completed, run by University of Iowa. The registered enrollment target is 124 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05832996, a Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
Background and Objective: To evaluate the efficacy of cooled versus room temperature artificial tears in reducing post intravitreal injection (IVI) ocular discomfort. Patients and Methods: Patients receiving IVI were randomized to either cooled or room temperature tears intervention groups. Both groups rated their ocular discomfort following IVI before intervention and again after administration of cooled or room temperature tears.
Conditions Studied
Interventions
- DRUG Refresh Plus Preservative-free Lubricant Eye Drops
Study Locations (1)
Iowa
- University of Iowa Hospitals & Clinics - Department of Ophthalmology - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-07-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05832996
The ClinicalTrials.gov registry entry for NCT05832996 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Cystoid Macular Edema appearing as the primary indexed condition, and to 1 intervention - of which Refresh Plus Preservative-free Lubricant Eye Drops is the first listed.
NCT05832996 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT05832996 about?
NCT05832996 is a clinical study titled "Cool vs Room-temperature Artificial Tears". Background and Objective: To evaluate the efficacy of cooled versus room temperature artificial tears in reducing post intravitreal injection (IVI) ocular discomfort. Patients and Methods: Patients receiving IVI were randomized to either cooled or room temperature tears intervention groups. Both gr...
What is the current status of trial NCT05832996?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2022-03-01. Estimated completion is 2022-07-06.
What conditions does trial NCT05832996 study?
This clinical trial studies the following conditions: Cystoid Macular Edema, Ocular Surface Disease, Central Retinal Vein Occlusion With Macular Edema, Eye Pain, Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis).
What interventions are being tested in trial NCT05832996?
The interventions under investigation include: Refresh Plus Preservative-free Lubricant Eye Drops (DRUG).
Who is sponsoring clinical trial NCT05832996?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05832996 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystoid Macular Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.